ES8106083A1 - Procedimiento para preparar una resina intercambiadora de cationes, medicada,secuencialmente cargada - Google Patents

Procedimiento para preparar una resina intercambiadora de cationes, medicada,secuencialmente cargada

Info

Publication number
ES8106083A1
ES8106083A1 ES493702A ES493702A ES8106083A1 ES 8106083 A1 ES8106083 A1 ES 8106083A1 ES 493702 A ES493702 A ES 493702A ES 493702 A ES493702 A ES 493702A ES 8106083 A1 ES8106083 A1 ES 8106083A1
Authority
ES
Spain
Prior art keywords
contain
companion animals
palatable
compositions
tablets
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES493702A
Other languages
English (en)
Other versions
ES493702A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of ES8106083A1 publication Critical patent/ES8106083A1/es
Publication of ES493702A0 publication Critical patent/ES493702A0/es
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/064—Saccharomycetales, e.g. baker's yeast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/407—Liver; Hepatocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Nutrition Science (AREA)
  • Biomedical Technology (AREA)
  • Physiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

PROCEDIMIENTO PARA PREPARAR UNA RESINA INTERCAMBIADORA DE CATIONES, MEDICADA, SECUENCIALMENTE CARGADA, DE FORMULA (I), DONDE R ES HIDROGENO O ALQUILO; R1 ES AQUILO, R2 ES ALQUILO Y R3 ES HIDROGENO O HALOGENO. EL PROCEDIMIENTO COMPRENDE HACER REACCIONAR UN COMPUESTO DE ESTIRILPIRIDINO CON UNA RESINA INTERCAMBIADORA DE CATIONES, DE ACIDO SULFONICO, EN SOLUCION ACUOSA. LA RESINA CARGADA SE LEVA CON AGUA DESIONIZADA Y SE HACE REACCIONAR CON UNA SOLUCION ACUOSA DE DIETILCARBAMAZIDA, LAVANDO Y SEPARANDO LA RESINA RESULTANTE. ESTOS COMPUESTOS SON DE UTILIDAD COMO COMPOSICIONES ANTIHELMINTICAS DEGUSTABLES PARA EL TRATAMIENTO DE HELMINTIASIS EN ANIMALES DOMESTICOS. *FORMULA*
ES493702A 1979-07-26 1980-07-24 Procedimiento para preparar una resina intercambiadora de cationes, medicada,secuencialmente cargada Granted ES493702A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US6093179A 1979-07-26 1979-07-26

Publications (2)

Publication Number Publication Date
ES8106083A1 true ES8106083A1 (es) 1981-08-01
ES493702A0 ES493702A0 (es) 1981-08-01

Family

ID=22032632

Family Applications (1)

Application Number Title Priority Date Filing Date
ES493702A Granted ES493702A0 (es) 1979-07-26 1980-07-24 Procedimiento para preparar una resina intercambiadora de cationes, medicada,secuencialmente cargada

Country Status (6)

Country Link
AU (1) AU5957480A (es)
DE (1) DE3028082A1 (es)
ES (1) ES493702A0 (es)
FR (1) FR2462162A1 (es)
GB (1) GB2055575A (es)
IT (1) IT1128534B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3719764A1 (de) * 1987-06-13 1988-12-22 Bayer Ag Ionenaustauscherharze beladen mit chinoloncarbonsaeurederivaten, ihre herstellung und verwendung
US5419897A (en) * 1993-04-09 1995-05-30 Buckman Laboratories International, Inc. Ionene polymers as anthelmintics in animals
DE69523912T2 (de) * 1994-05-20 2002-06-27 Janssen Pharmaceutica N.V., Beerse Flubendazole-kautabletten für haustiere
US7067116B1 (en) 2000-03-23 2006-06-27 Warner-Lambert Company Llc Fast dissolving orally consumable solid film containing a taste masking agent and pharmaceutically active agent at weight ratio of 1:3 to 3:1
WO2002072069A1 (en) * 2001-03-12 2002-09-19 Novo Nordisk A/S Novel tablets and capsules and a process for its preparation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH383552A (de) * 1958-10-24 1964-10-31 Clinical Products Limited Verfahren zur Herstellung von Harz-Arzneistoffverbindungen
GB899720A (en) * 1960-08-15 1962-06-27 American Cyanamid Co Anthelmintic animal feed
US3177116A (en) * 1962-01-26 1965-04-06 American Cyanamid Co Anthelmintic compositions containing substituted styrylpyridinium compounds and method of administering same

Also Published As

Publication number Publication date
DE3028082A1 (de) 1981-02-19
IT8049307A0 (it) 1980-07-23
ES493702A0 (es) 1981-08-01
AU5957480A (en) 1981-01-29
IT1128534B (it) 1986-05-28
FR2462162A1 (fr) 1981-02-13
GB2055575A (en) 1981-03-11

Similar Documents

Publication Publication Date Title
GB1405088A (en) Slow release formulation
NO863061D0 (no) Fremgangsmaate for fremstilling av fysiologisk aktive fenoksyeddiksyrederivater.
IT1185550B (it) Miscele non polverose di sfarinati o farine con principi attivi per mangimistica
DE3376799D1 (en) Gel-like ointment containing indomethacin
EP0009688A3 (en) Medicated animal food based on liver powder, process for its preparation and its use in combating animal diseases
ES2149990T3 (es) Composiciones farmaceuticas solidas que contienen ingrediente activo de acido (s)-2-(4-isobutilfenil)propionico y celulosa microcristalina y silice coloidal como excipientes.
ES8406448A1 (es) Procedimiento para la preparacion de fenilsulfoniloxibencimidazolcarbamatos sustituidos
CA2487648A1 (en) Pharmaceutical preparations for oral administration, containing ion-exchange resins loaded with active ingredients and intrinsically viscous gelling agents as thickening agents
DE3267295D1 (en) Stable s-adenosylmethionine salts, the process for their preparation and therapeutic compositions which contain them as active principle
ES8106083A1 (es) Procedimiento para preparar una resina intercambiadora de cationes, medicada,secuencialmente cargada
IL61207A0 (en) Cytostatically active pharmaceutical compositions comprising isocyanuric acid derivatives, certain such novel derivatives and their preparation
HUT45531A (en) Process for producing bactericidal compositions, fodder additives and 7-azabicycloalkyl-quinolonecarboxylic acid and naphthiridinecarboxylic acid derivatives applicable as active ingredient
DE3584608D1 (de) Amidabkoemmlinge.
IE791995L (en) Formulation
DE3060682D1 (en) Process for preparing highly concentrated finely dispersed solid compositions of water insoluble to slightly soluble active compounds dispersible in an aqueous medium, containing little or no dispersing agent
AU6250680A (en) Phosphono-hydroxy-acetic acid
DK209384D0 (da) 4-phenyl-tetrahydro-furano-pyridiner og syreadditionssalte deraf,fremgangsmaade til deres fremstilling og farmaceutiske kompositioner indeholdende forbindelserne
EP0112061A3 (en) Pharmaceutical or veterinary compositions containing guanoxabenz
DK401683D0 (da) Substituerede benzensulfonsyreestere, fremgangsmade til deres fremstilling og deres anvendelse som laegemidler
ES8304429A1 (es) Un procedimiento para la preparacion de soluciones minerales acuosas estables de levonantradol y n-metil-levonantradol.
MY101266A (en) Pharmaceutical formulations
ATE15329T1 (de) Pharmazeutische grundmasse und praeparate.
GB1129299A (en) Composition and method for the prophylactic treatment of parturient paresis
GB1119636A (en) A novel imidazole derivative and a novel intermediate therefor
GB966685A (en) Improvements in or relating to vitamin k compositions